Table 2.
Cell types and their role in the pathogenesis of OLP
| Cell Type | Role in Pathogenesis |
|---|---|
| Keratinocytes | Express MHC-I and MHC-II (when stimulated), release inflammatory mediators and undergo apoptosis/pyroptosis |
| Langerhans cells | Once activated, they migrate from the epithelium to the lymph nodes and present antigens to naive T cells |
| Dendritic cells | Present antigens to T lymphocytes |
| Näive T cell | Differentiates into effector subtypes following activation by APCs |
| Th1 | Produces IFN-γ, IL-2 and TNF-α, exacerbating inflammation and promoting TCD8+activation |
| Th2 | Modulates the inflammatory response and contributes to less aggressive forms of OLP |
| Th17 | Secretes pro-inflammatory cytokines, amplifying inflammation and tissue destruction |
| Treg | Produces IL-10 and TGF-β, regulates inflammation and balances the immune response |
| TCD8+ cell | Induces keratinocyte apoptosis through perforin/granzyme B release, FasL/Fas interaction and TNF-α signaling |
| MAIT cell | Produce granzyme B contributing to apoptosis and possibly pyroptosis of keratinocytes |
| M1 macrophage | Promote chronic inflammation through antigen presentation and secretion of TNF-α and IL-1β |
| M2 macrophage | Have an anti-inflammatory or pro-reparative function |
| Mast cells | Amplify inflammation through the release of inflammatory mediators and angiogenic factors. They activate MMP-9 and contribute to the rupture of the basement membrane |
| Fibroblasts | Promote angiogenesis, induce proliferation and migration of CD4 + T and inhibit their apoptosis |